14-99510402-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001099402.2(CCNK):c.1363G>A(p.Gly455Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000109 in 1,560,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 23)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
CCNK
NM_001099402.2 missense
NM_001099402.2 missense
Scores
3
1
15
Clinical Significance
Conservation
PhyloP100: 7.05
Genes affected
CCNK (HGNC:1596): (cyclin K) The protein encoded by this gene is a member of the transcription cyclin family. These cyclins may regulate transcription through their association with and activation of cyclin-dependent kinases (CDK) that phosphorylate the C-terminal domain (CTD) of the large subunit of RNA polymerase II. This gene product may play a dual role in regulating CDK and RNA polymerase II activities. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.15694782).
BS2
High AC in GnomAdExome4 at 16 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCNK | NM_001099402.2 | c.1363G>A | p.Gly455Arg | missense_variant | 11/11 | ENST00000389879.9 | NP_001092872.1 | |
CCDC85C | NM_001144995.2 | c.*4844C>T | 3_prime_UTR_variant | 6/6 | ENST00000380243.9 | NP_001138467.1 | ||
CCNK | XM_005268154.5 | c.1363G>A | p.Gly455Arg | missense_variant | 11/11 | XP_005268211.1 | ||
CCNK | XM_047431839.1 | c.1363G>A | p.Gly455Arg | missense_variant | 12/12 | XP_047287795.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCNK | ENST00000389879.9 | c.1363G>A | p.Gly455Arg | missense_variant | 11/11 | 5 | NM_001099402.2 | ENSP00000374529 | P1 | |
CCDC85C | ENST00000380243.9 | c.*4844C>T | 3_prime_UTR_variant | 6/6 | 5 | NM_001144995.2 | ENSP00000369592 | P1 | ||
CCNK | ENST00000555049.5 | c.1117+3255G>A | intron_variant | 1 | ENSP00000452307 | |||||
CCNK | ENST00000553865.1 | n.4515G>A | non_coding_transcript_exon_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000668 AC: 1AN: 149774Hom.: 0 Cov.: 23
GnomAD3 genomes
AF:
AC:
1
AN:
149774
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000604 AC: 1AN: 165464Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 88920
GnomAD3 exomes
AF:
AC:
1
AN:
165464
Hom.:
AF XY:
AC XY:
0
AN XY:
88920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000113 AC: 16AN: 1410346Hom.: 0 Cov.: 35 AF XY: 0.00000718 AC XY: 5AN XY: 696688
GnomAD4 exome
AF:
AC:
16
AN:
1410346
Hom.:
Cov.:
35
AF XY:
AC XY:
5
AN XY:
696688
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000668 AC: 1AN: 149774Hom.: 0 Cov.: 23 AF XY: 0.0000137 AC XY: 1AN XY: 72946
GnomAD4 genome
AF:
AC:
1
AN:
149774
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
72946
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual developmental disorder with hypertelorism and distinctive facies Uncertain:1Other:1
not provided, no classification provided | phenotyping only | GenomeConnect - Brain Gene Registry | - | Variant classified as Uncertain significance and reported on 06-21-2021 by New York Genome Center. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 21, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of catalytic residue at Y458 (P = 0);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at